How to successfully validate flow cytometry assays for cell and gene therapies [WEBINAR]

As cell and gene therapies are becoming increasingly important for the treatment of cancers and other diseases, the need for reliable characterization of such therapies is skyrocketing.
Flow cytometry has emerged as a key methodology for the analysis of cell and gene therapies during research, clinical manufacturing, and follow-up in patients. However, reproducibility of results is often hampered by a lack of operator experience, quality reagents and stable instruments, as well as regulatory guidance on essential reagent, instrument, and software requirements. Additionally, scientists often find themselves completely on their own when it comes to assay qualification and validation for clinical trials.
In this webinar Join Zhaojun Yin, Senior Scientist at Genentech (CA, USA) and Marsilius Mues, R&D Group Leader at Miltenyi Biotec talk about how they approach assay qualification and validation and what they consider for reliable flow cytometry analytics for cell and gene therapeutic products.
Learn more about standardizing flow cytometry assays in cell manufacturing:
www.miltenyibi...
Or simply watch our video on how we support your standardized flow cytometry assays:

[@jatin1995]

Great talk